Lee Health Heart Institute Reaches 100-Patient Milestone in Global LeAPPS Stroke Prevention Trial
Key Insights
Lee Health Heart Institute (search) has enrolled its 100th patient in the international LeAPPS Clinical Trial (search), positioning it among only 115 global research sites investigating left atrial appendage (search) exclusion for stroke (search) prevention.
The groundbreaking study focuses on preventing stroke (search) and systemic embolism (search) in patients with risk factors for atrial fibrillation (search) and ischemic stroke (search) undergoing cardiac surgery.
Principal investigator Dr. David Cervantes highlights that this research could significantly enhance patient care by developing new preventive strategies during cardiothoracic surgeries and improving long-term outcomes.
The Lee Health Heart Institute (search) has reached a significant research milestone by enrolling its 100th patient in the groundbreaking LeAPPS Clinical Trial (search), an international study investigating stroke (search) prevention strategies for cardiac surgery patients.
As one of only 115 research sites worldwide and just 10 in Florida participating in this global initiative, the Lee Health Heart Institute (search) is playing a pivotal role in advancing cardiovascular care. The trial specifically examines the effectiveness of left atrial appendage (search) exclusion in preventing stroke (search) and systemic embolism (search) in patients with risk factors for atrial fibrillation (search) and ischemic stroke (search).
"It's an honor to participate in this essential trial to help reduce stroke (search) risks for cardiac surgery patients," said Dr. David Cervantes, cardiothoracic surgeon with Lee Health and principal investigator for the study. "We believe these results will significantly enhance patient care in Southwest Florida and help our community access top-quality treatment close to home."
Clinical Significance of the LeAPPS Trial
Stroke (search) remains a leading cause of disability and mortality worldwide, with atrial fibrillation (search) significantly increasing risk. The left atrial appendage (search), a small pouch in the heart's left atrium, is known to be a common site for blood clot formation in patients with atrial fibrillation, which can lead to stroke if these clots enter the bloodstream.
The LeAPPS trial investigates whether surgical exclusion of this appendage during cardiac procedures could provide an effective preventive strategy for patients with risk factors for atrial fibrillation (search), even if they haven't yet developed the condition.
This research could potentially transform standard protocols for cardiac surgeries by incorporating preventive measures that might significantly reduce stroke (search) risk in vulnerable populations.
Southwest Florida's Growing Role in Clinical Research
This milestone reinforces the Heart Institute's position as a research-driven, life-saving hub in Southwest Florida, bringing world-class clinical innovation to the local community. By participating in cutting-edge clinical trials like LeAPPS, the institute not only contributes to shaping the future of cardiac care but also ensures that patients in Southwest Florida benefit from the latest advances in medical science.
The Lee Health Heart Institute (search) is the largest heart program in Southwest Florida, offering comprehensive cardiac services including primary and specialty care, advanced cardiac imaging, cardiothoracic surgery, and cardiac rehabilitation. The institute emphasizes a collaborative approach to cardiac care, with cardiac imaging experts working closely with referring physicians to develop personalized care plans tailored to each patient's unique needs.
Potential Impact on Cardiac Surgery Protocols
If successful, the LeAPPS trial could establish new standard preventive strategies during cardiothoracic surgeries, potentially lowering stroke (search) risk and driving better long-term outcomes for countless patients globally.
The trial's focus on patients with risk factors rather than established atrial fibrillation (search) represents an important shift toward preventive intervention, potentially expanding the population that could benefit from left atrial appendage (search) exclusion procedures.
As the trial progresses, the Lee Health Heart Institute (search) will continue to play a crucial role in this international research effort, further cementing its position as a leader in cardiovascular research and patient care in the region.